Shenzhen Hepalink Pharmaceutical Co., Ltd.(002399.SZ)
Profile
Registered Capital:
800.20(RMB MLN)
Employees：
615
Email：
stock@hepalink.com
WebSite：
http://www.hepalink.com
Tel：
0755-26980311
Fax：
0755-26980183
Shenzhen Hepalink Pharmaceutical Co., Ltd. is principally engaged in the research, production and distribution of heparin sodium bulk drugs. The Company primarily offers heparin sodium products, including Food and Drug Administration (FDA) grade heparin sodium ingredients and ordinary grade heparin sodium ingredients. The Company distributes its products in domestic and overseas markets. As of December 31, 2010, the Company had five subsidiaries and one affiliate, which involved in the processing of heparin materials, the development of biological pharmaceutical technologies, the production of injections, as well as import and export businesses, among others.
Reports
- In-depth Report of Shenzhen Hepalink Pharmaceutical Co., Ltd.(002399.SZ)
- Credit Report of Shenzhen Hepalink Pharmaceutical Co., Ltd.(002399.SZ)
- Financial Report of Shenzhen Hepalink Pharmaceutical Co., Ltd.(002399.SZ)
- China Heparin Industry Report, 2015-20182015/12/15
- China Heparin Industry Report, 2014-20172014/10/20
- China Chemical Pharmaceutical Industry Report, 2013-20162014/6/4
- China Heparin Industry Report, 2013-20152013/10/10
- China Heparin Industry Report, 2012-20142012/12/4
- China Chemical Pharmaceutical Industry Report, 20112012/1/17
- China Heparin Industry Report, 2010-20112011/9/28
Shenzhen Hepalink Pharmaceutical Co., Ltd. focuses on the production of injectable grade heparin products in China and internationally. It offers heparin sodium and heparin calcium products to pharmaceutical companies. The company, formerly known as Chongqing Tongda Biological Products Co., Ltd., was founded in 1986 and is based in Shenzhen, China.